My comment relates specifically to recurring revenue, not repeat. They are different, and yes, valued differently by 'the market'. It is telling that they have combined the 2 in their '60%' commentary.
Managements comment re R&D initiatives to generate recurring revenue streams in 12 to 24 months suggests they get it.
- Forums
- ASX - By Stock
- VOR
- Ann: Appendix 4C and commentary - quarterly
Ann: Appendix 4C and commentary - quarterly, page-44
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)